Devices which incorporate an ancillary medicinal substance
- Medicines and Healthcare products Regulatory Agency
- Part of:
- Regulatory guidance for medical devices
- First published:
- 13 May 2016
Guidance for notified bodies: devices which incorporate an ancillary medicinal substance
PDF, 194KB, 33 pages
This file may not be suitable for users of assistive technology. Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email email@example.com. Please tell us what format you need. It will help us if you say what assistive technology you use.
NOTE: This is guidance that was first published in 2011 on the previous MHRA website. It is currently being updated and will be published shortly.
This Guidance is for Notified Bodies and their client companies wishing to consult the Medicines and Healthcare products Regulatory Agency (MHRA) with regard to the ancillary medicinal substance incorporated in a medical device.
Published: 13 May 2016